Daily Roundup

Crimson Consulting Extends Kip McGrath Takeover Offer

Crimson Consulting has pushed back the deadline for its takeover of Kip McGrath Education Centres, with the offer now closing on 27 October 2026. The extension was triggered automatically after Crimson's voting power crossed the 50% threshold during the original offer period. The move represents a shift in sentiment from Kip McGrath's board, which has now unanimously recommended shareholders accept the offer—a change from their previous stance.

WiseTech Global Clears ASIC Hurdles

WiseTech Global has put regulatory concerns to rest with the conclusion of an ASIC investigation into alleged share trading and governance matters. The regulator issued no-action letters to three current WiseTech employees and to the company itself, meaning no enforcement action will be taken. An investigation into one non-employee remains ongoing, but the company and its staff are in the clear.

Fiducian Delivers Mixed Quarterly Results

Fiducian Group's latest quarter tells a story of two speeds. The core Fiducian platform attracted $54 million in net inflows, though that's down from $102 million the previous quarter. Legacy adviser operations saw $22 million flow out the door. On the brighter side, funds under management, administration and advice reached $15.4 billion, and the badged platform balance climbed to $261 million. The company did take a $7.95 million hit from an ASIC penalty, but that's now behind them.

The group's full-year results paint a more optimistic picture. Operating revenue jumped 8% to $96.1 million, while net revenue climbed 9% to $74.4 million. Underlying net profit after tax surged 15% to $24.2 million, and the board rewarded shareholders with a fully franked dividend of 53.7 cents per share. Fiducian is also planning to deploy AI agents to boost productivity and client service.

Medical Developments Hits Growth Stride, Then Shakes Up Leadership

Medical Developments International delivered impressive momentum in its latest quarter, with Penthrox showing real traction in key markets. European in-market volumes jumped 37%, buoyed by a newly approved paediatric label, while Australian hospital volumes grew 24%. The company maintained tight cost control and improved operating cashflows despite a slight revenue dip overall.

That positive momentum comes with a leadership curveball. CEO Brent MacGregor is stepping down, with CFO Anita James stepping into the interim role effective immediately. MacGregor will stick around in an advisory capacity until mid-November while the board hunts for a permanent replacement.

DroneShield Scales Up on Strong Revenue Trajectory

DroneShield is firing on all cylinders with FY2026 committed revenue hitting $261 million—right at the midpoint of its guidance range and a 35% jump from the prior year. That translates to an average of $5 million in weekly revenue. The company has also locked in $29 million in committed revenue for FY2027 and $17 million for FY2028 and beyond, signaling sustained demand.

The company is backing up its confidence with expansion, opening a new 3,000 sqm facility in Australia and adding manufacturing capabilities in Europe. DroneShield is also rolling out next-generation products, including the RfAI-3 powered RfRecon, while building an open, interoperable ecosystem designed for multi-layered deployment across military and non-military segments.